Since April, the Trump administration has funneled $48 million into a program with the Mayo Clinic, allowing more than 53,000 Covid-19 patients to get plasma infusions. Doctors and hospitals desperate to save the sickest patients have been eager to try a therapy that is safe and might work. Many patients and their doctors — knowing they could get the treatment under the government program — have been unwilling to join clinical trials that might provide them with a placebo. The policy would ease the clerical burden on hospitals to get clearance for transfusions, further hampering clinical trials, researchers said. Scientists believe it may work by giving sick patients the antibodies of those who have recovered from the infection.
Source: New York Times August 05, 2020 09:24 UTC